Max Robotics — Global Service Robot Directory + US Certification

About

Hidefumi Shiroshita is a leading figure in the advancement of minimally invasive surgery, with a primary focus on laparoscopic and endoscopic techniques for gastrointestinal cancers. His major contributions center on establishing high-quality evidence for laparoscopic gastrectomy (LAG) in gastric cancer treatment, notably through large-scale clinical studies that have helped standardize and refine procedures like laparoscopy-assisted distal gastrectomy (LADG) in Japan. Shiroshita’s work also provides critical insights into the impact of the COVID-19 pandemic on elective surgeries, using national databases to analyze surgical outcomes and adaptations during 2020–2021. His most-cited paper, the 16th National Survey of Endoscopic Surgery (2024, 17 citations), offers a comprehensive snapshot of the field’s evolution since laparoscopic cholecystectomy was introduced in Japan in 1990. With additional studies on postoperative outcomes during COVID-19 (3–8 citations), Shiroshita’s research is vital for surgeons navigating both routine practice and crisis scenarios. His ongoing efforts continue to shape the future of minimally invasive surgery, ensuring patient safety and procedural excellence.